Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03039257 · ClinicalTrials.gov registry record · NA
Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates
A NA study of Hematopoietic Stem Cell Transplant, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03039257: Completed NA study of Hematopoietic Stem Cell Transplant, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT03039257 is a NA study of Hematopoietic Stem Cell Transplant that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 12 participants, below the 103-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03039257, a NA study of Hematopoietic Stem Cell Transplant, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to establish that single dose vitamin A supplementation is feasible and safe in pediatric and young adult bone marrow transplant recipients until day +30 (± 7 days) after hematopoietic stem cell transplantation.
Primary Outcome
Vitamin A level will be measured 30 days after HSCT.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin A
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-02-02 |
| Est. Completion | 2018-03-28 |
| Phase | NA |
What the finished NCT03039257 record still lists
NCT03039257 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 103-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Hematopoietic Stem Cell Transplant appearing as the primary indexed condition, and to 1 intervention - of which Vitamin A is the first listed.
NCT03039257 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03039257 about?
NCT03039257 is a clinical study titled "Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates". The primary objective of this study is to establish that single dose vitamin A supplementation is feasible and safe in pediatric and young adult bone marrow transplant recipients until day +30 (± 7 days) after hematopoietic stem cell transplantation.
What is the current status of trial NCT03039257?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-02-02. Estimated completion is 2018-03-28.
What conditions does trial NCT03039257 study?
This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplant.
What interventions are being tested in trial NCT03039257?
The interventions under investigation include: Vitamin A (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03039257?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03039257 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic Stem Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03039257's enrollment target sits among peer trials
12 8th of 8 higher than 1 of 8 other Hematopoietic Stem Cell Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematopoietic Stem Cell Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
RECRUITING · NA
-
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
RECRUITING · NA
-
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
RECRUITING · NA
-
Music Therapy and Hematopoietic Stem Cell Transplant
COMPLETED · NA
-
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RECRUITING · Phase 1
-
T Cell Therapy of Opportunistic Cytomegalovirus Infection
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI